An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

NCT00803101 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
176
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CSL Behring